#SpaceXQuietPeriodEnds

SpaceX: The Quiet Period Ends, and Wall Street Can't Agree on a $1 Trillion Question

The 25-day silence is over. On July 7, the mandatory quiet period expired for the 23 investment banks that underwrote SpaceX's record-shattering IPO—and the floodgates opened with a vengeance. What emerged wasn't consensus. It was chaos.

Morgan Stanley's Adam Jonas led the charge with a Street-high $300 price target, effectively calling for an 87% rally from current levels. His thesis? SpaceX isn't just a rocket company anymore—it's a planetary infrastructure play sitting at the intersection of three trillion-dollar markets: space access, global connectivity, and AI compute. Jonas sees revenues hitting $3.3 trillion by 2040, a figure that would make SpaceX larger than the entire U.S. tech sector today.

Goldman Sachs, the other lead underwriter, took a more sober view. Eric Sheridan's team slapped a $205 target on the stock—still bullish, but $95 below Morgan Stanley's call. That $1 trillion valuation gap between two banks who sat in the same underwriting syndicate tells you everything about how divided the Street is on this name.

UBS came in at $210. RBC at $225. Macquarie at $250. Raymond James went full throttle with an $800 target. And then there was CFRA.

While the bulge brackets were tripping over themselves to out-bull each other, CFRA's Keith Snyder issued a rare Sell rating with a $115 price target—15% below the $135 IPO price. His argument wasn't about Musk's vision or Starlink's potential. It was about execution risk and capital intensity.

Snyder's concern centers on Starship. The vehicle that Morgan Stanley is counting on to drive launch costs below $150/kg by 2040 is still, in CFRA's view, stuck in development hell. Every month of delay burns cash. Every test failure pushes commercialization further out. And SpaceX's free cash flow profile—negative until 2035 according to Morgan Stanley's own estimates—means the company will be asking investors to fund this dream for years to come.

The $115 target implies a $1.5 trillion valuation, or 20.2x CFRA's 2027 sales estimate. That's not cheap. It's just less absurd than the $300 target.

Here's what both sides are missing: SpaceX is already trading like a meme stock wrapped in a space suit. The company went public at a $1.77 trillion valuation—triple the size of Alibaba's record-breaking 2014 IPO—and promptly joined the Nasdaq-100. Retail ownership is through the roof. The stock moves on Musk's tweets, not cash flows.

Morgan Stanley's $3.3 trillion revenue forecast for 2040 assumes SpaceX becomes a dominant player in orbital data centers, AI inference at scale, and global energy markets. That's not a forecast. That's science fiction with a Bloomberg terminal.

But CFRA's bear case isn't bulletproof either. Betting against Musk has been a widow-making trade for two decades. Tesla shorts lost $40 billion. The people who laughed at reusable rockets in 2015 aren't laughing now. SpaceX has defied physics and finance before. It might do it again.

If you're holding SpaceX at $160, you're sitting between two radically different visions of the future. Morgan Stanley sees a $5 trillion company. CFRA sees a $1.5 trillion company. The truth is probably somewhere in the middle—and that middle is still a volatile, capital-intensive, execution-dependent bet on technologies that don't fully exist yet.

The quiet period ended. The noise is just beginning.